Microstream™ capnography monitoring should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment. Review the full product IFU before use by appropriate personnel.
†Testing funded and conducted by Medtronic; bench results may not be indicative of clinical performance. Bench tests compared performance of sampling lines commonly used with spontaneous breathing patients under various breathing conditions. Three categories of sampling line products were evaluated including oralnasal cannulas (n=9).
1. Jones T, Glozman D, Oglesby H, Mulier JP. Comparative Analysis of Accuracy, Filter Performance, and Durability among Capnography Sampling Lines: A Bench Study. Medtronic Manuscript. 2024.
2. Maddox R, Williams CK, Oglesby H, et al. Clinical experience with patient-controlled analgesia using continuous respiratory monitoring and a smart infusion system. Am J Health Syst Pharm. 2006;63(2):157-164.
3. Khanna AK, Overdyk FJ, Greening C, Di Stefano P, Buhre WF. Respiratory depression in low acuity hospital settings-Seeking answers from the PRODIGY trial. J Crit Care. 2018;47:80-87. doi:10.1016/j.jcrc.2018.06.014
4. Khanna AK, Bergese SD, Jungquist CR, et al. Prediction of Opioid-Induced Respiratory Depression on Inpatient Wards Using Continuous Capnography and Oximetry: An International Prospective, Observational Trial. Anesth Analg. 2020;131(4):1012-1024. doi:10.1213/ANE.0000000000004788
5. Waugh JB, Gardner DD, Vines DL. Effect of heliox on end-tidal CO2 measurement in healthy adults. Respir Care. 2013;58(11):1945-1948. doi:10.4187/respcare.02183
6. Internal test data on le.
7. Alaris™* EtCO2 Module Model 8300 Monitor Accessory Compatibility Card [instructions for use]. Franklin Lakes, NJ: Becton Dickinson; 2008, 2016.
™* Third–party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.